Company History

corporate office

Fresenius Medical Care’s history in health care spans hundreds of years, beginning with a 15th century pharmacy in Frankfurt, Germany. Click here for the company’s historic timeline.

Here’s how Fresenius Medical Care’s North American operations came to be and have continued to grow.


Fresenius Medical Care North America timeline


North America Hq

In two separate transactions, FMCNA acquires MedSpring Urgent Care and invests in Sound Physicians, advancing its goal to create the preeminent network of providers to tend to the needs of chronically ill patients.


FMCNA acquires American Access Care, which becomes Fresenius Vascular Care, to enhance kidney patient access to high-quality outpatient vascular care.

FMCNA acquires dialysis provider Liberty Dialysis Holdings, renowned for its home dialysis programs and efficient hemodialysis health care model.


The Centers for Medicare and Medicaid Services (CMS) publishes the conclusions of the FHP demonstration project with Medicare beneficiaries on dialysis. The project resulted in improved overall health outcomes for patients while reducing the overall cost of care.


FMCNA launches FreseniusRx pharmacy to enable patients to order and receive medications and supplies directly from renal pharmacists who are specially trained in treating and counseling patients living with kidney disease.

FMCNA buys Health IT Services Group, bringing Acumen, the first nephrology-specific electronic health record, into the organization.


Fresenius Health Partners (FHP), a subsidiary of FMCNA, and CMS begin a three-year demonstration project with Medicare beneficiaries on dialysis to test the impact of disease management on Medicare’s ESRD population.

FMCNA acquires dialysis provider Renal Care Group and subsequently incorporates the Medical Advisory Board structure within the FMCNA Medical Office.


FMCNA launches its Advanced Renal Education Program, developed to assist nephrologists and professional dialysis staff in improving clinical outcomes and standards of practice.


FMCNA begins the process of discontinuing the reuse of dialyzers in its clinics.


FMCNA and Beth Israel Medical Center enter into a joint venture, forming Renal Research Institute (RRI). RRI combines optimal treatment with innovative technologies to improve the outcomes of dialysis patients.

FMCNA buys Spectra Laboratories, Inc., the largest independent kidney dialysis lab in the United States.


Fresenius USA, Inc. and National Medical Care’s North American dialysis businesses merge, forming Fresenius Medical Care North America (FMCNA), becoming the continent’s leading dialysis provider and renal products manufacturer.

Fresenius Medical Care’s shares are listed at the stock exchanges in Frankfurt and New York.

In this section: